ANXA5 and stroke disorder: It has been demonstrated that CD34+, CD56+/Annexin V+ EV, labeled neural progenitor cell-derived vesicles, are also increased over a prolonged period post-stroke compared to patients matched for cardiovascular risk (22), which the authors interpreted as an indicator for breakdown of blood–brain barrier.